The mission of Georgia Health Sciences University (GHSU) is to lead Georgia and the
world to better health by providing excellence in biomedical education, discovery,
and service. Our vision is to be a globally recognized research university and academic
health center, while transforming the region into a health care and biomedical research
destination.
Clinical and translational research programs at GHSU focus on three key areas that disproportionately affect the health of Georgians:
cancer, cardiometabolic disease, and neurological disease including stroke. We are also developing three
emerging areas of research strength: regenerative & reparative medicine, personalized
medicine & genomics, and public and preventive health.
Our state of-the-art research facilities, collaborative research environment, and
outstanding clinical resources place GHSU at the leading edge of new scientific advancements
targeting diseases that directly impact our patient population. We look forward to
working with you as we move forward during this exciting period of research growth
and discovery.
Early life stress like that experienced by ill newborns appears to take an early toll of the heart, affecting its ability to relax and refill with oxygen-rich blood, researchers report. Rat pups separated from their mothers a few hours each … Continue reading →
AUGUSTA, Ga. – The Joint Commission on the Accreditation of Health Care Organizations has designated Georgia Regents Medical Center as an Advanced Comprehensive Stroke Center, making it the only hospital in Georgia and one of less than 20 hospitals nationwide to achieve this designation. Continue reading →
Dr. Samir N. Khleif, Director of the Georgia Regents University Cancer Center, is one of 100 international cancer experts who were invited to participate in the World Oncology Forum (WOF), who are calling on governments around the world today - World Cancer Day - to take urgent action to halt a catastrophic increase in death and suffering from cancer across the globe, and to deliver on commitments they made at the World Health Assembly in May 2012 to cut premature deaths from non-communicable diseases, including cancer, by 25% by 2025. Continue reading →
The editorial posted in the June 22 issue of Science (p. 1491) by Charles O. Holliday, former chairman and chief executive officer of E. I. du Pont de Nemours and Company, highlights several conclusions from the National Research Council (NRC) … Continue reading →
Steven Houser of Temple University provides helpful commentary in the May 30 issue of Circulation Research (v. 110, p. 907) on what makes a young investigator a a successful applicant for the mentored clinical scientist (K08) and pathway to independence … Continue reading →
David Wheeler writes in the April 15 issue of Chronicle of Higher Education as well as his Planet Academe blog about the growth of biomedical research in Asia. The National Science Foundation’s Science and Engineering Indicators provides additional data on … Continue reading →
Paula Stephan, author of “The Economics of Science” writes in her article, “Research efficiency: Perverse incentives” available in the April 5 issue of Nature (p. 29) that current financial incentives in biomedical research are actually decreasing return on investment and have … Continue reading →
